Turk Ilac ve Serum Sanayi AS
Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. The company was founded in 2010 and is headquartered in Ankara, Turkey.
Market Cap & Net Worth: Turk Ilac ve Serum Sanayi AS (TRILC)
Turk Ilac ve Serum Sanayi AS (IS:TRILC) has a market capitalization of $72.37 Million (TL2.57 Billion) as of March 19, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #22951 globally and #310 in its home market, demonstrating a 3.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Turk Ilac ve Serum Sanayi AS's stock price TL15.86 by its total outstanding shares 161805000 (161.81 Million).
Turk Ilac ve Serum Sanayi AS Market Cap History: 2021 to 2026
Turk Ilac ve Serum Sanayi AS's market capitalization history from 2021 to 2026. Data shows growth from $53.38 Million to $72.37 Million (24.61% CAGR).
Turk Ilac ve Serum Sanayi AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Turk Ilac ve Serum Sanayi AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Turk Ilac ve Serum Sanayi AS's market cap is 0.03 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.06x
Turk Ilac ve Serum Sanayi AS's market cap is 1.06 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $53.38 Million | $672.60 Million | $37.14 Million | 0.08x | 1.44x |
| 2022 | $61.51 Million | $833.44 Million | $66.38 Million | 0.07x | 0.93x |
| 2023 | $52.15 Million | $2.77 Billion | $152.63 Million | 0.02x | 0.34x |
| 2024 | $76.43 Million | $2.57 Billion | $72.36 Million | 0.03x | 1.06x |
Competitor Companies of TRILC by Market Capitalization
Companies near Turk Ilac ve Serum Sanayi AS in the global market cap rankings as of March 19, 2026.
Key companies related to Turk Ilac ve Serum Sanayi AS by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Turk Ilac ve Serum Sanayi AS Historical Marketcap From 2021 to 2026
Between 2021 and today, Turk Ilac ve Serum Sanayi AS's market cap moved from $53.38 Million to $ 72.37 Million, with a yearly change of 24.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL72.37 Million | -1.37% |
| 2025 | TL73.37 Million | -4.00% |
| 2024 | TL76.43 Million | +46.54% |
| 2023 | TL52.15 Million | -15.21% |
| 2022 | TL61.51 Million | +15.21% |
| 2021 | TL53.38 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Turk Ilac ve Serum Sanayi AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $72.37 Million USD |
| MoneyControl | $72.37 Million USD |
| MarketWatch | $72.37 Million USD |
| marketcap.company | $72.37 Million USD |
| Reuters | $72.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.